BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 29936197)

  • 21. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic significance of tumor deposits in patients with stage Ⅲ colon cancer].
    Qi QH; Wang T; Mao Y; Hua D
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):784-789. PubMed ID: 27784466
    [No Abstract]   [Full Text] [Related]  

  • 23. Lymph node retrieval in colorectal cancer: determining factors and prognostic significance.
    Betge J; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
    Int J Colorectal Dis; 2017 Jul; 32(7):991-998. PubMed ID: 28210855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of classified extramural tumor deposits and extracapsular lymph node invasion in T3-4 colorectal cancer: a retrospective single-center study.
    Yamano T; Semba S; Noda M; Yoshimura M; Kobayashi M; Hamanaka M; Beppu N; Yano A; Tsukamoto K; Matsubara N; Tomita N
    BMC Cancer; 2015 Nov; 15():859. PubMed ID: 26545360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Oncotarget; 2016 Feb; 7(5):6335-44. PubMed ID: 26695441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of perineural invasion in patients with colorectal cancer.
    Hu G; Li L; Hu K
    Medicine (Baltimore); 2020 Apr; 99(17):e19860. PubMed ID: 32332645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
    Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
    J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
    Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
    Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.
    Liang L; Zhu J; Jia H; Huang L; Li D; Li Q; Li X
    Oncotarget; 2016 Jan; 7(1):1014-28. PubMed ID: 26510910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
    Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
    Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Log odds of positive lymph nodes as a prognostic indicator in stage IV colorectal cancer patients undergoing curative resection.
    Ozawa T; Ishihara S; Sunami E; Kitayama J; Watanabe T
    J Surg Oncol; 2015 Mar; 111(4):465-71. PubMed ID: 25690280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer?
    Song YX; Gao P; Wang ZN; Liang JW; Sun Z; Wang MX; Dong YL; Wang XF; Xu HM
    PLoS One; 2012; 7(3):e34087. PubMed ID: 22461900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node ratio may predict relapse free survival and overall survival in patients with stage II & III colorectal carcinoma.
    Zekri J; Ahmad I; Fawzy E; Elkhodary TR; Al-Gahmi A; Hassouna A; El Sayed ME; Ur Rehman J; Karim SM; Bin Sadiq B
    Hepatogastroenterology; 2015; 62(138):291-4. PubMed ID: 25916051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
    Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
    Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of lymph node ratio in esophageal cancer.
    Wang N; Jia Y; Wang J; Wang X; Bao C; Song Q; Tan B; Cheng Y
    Tumour Biol; 2015 Apr; 36(4):2335-41. PubMed ID: 25412956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.
    Osumi H; Shinozaki E; Suenaga M; Wakatsuki T; Nakayama I; Matsushima T; Ogura M; Ichimura T; Takahari D; Chin K; Nagasaki T; Konishi T; Akiyoshi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Yamaguchi K
    PLoS One; 2017; 12(5):e0176745. PubMed ID: 28562679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining stage III disease in colorectal cancer--aspects on treatment and evaluation of survival.
    Derwinger K; Carlsson G; Ekman T
    J Surg Oncol; 2010 Oct; 102(5):424-7. PubMed ID: 20607755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.